{
    "clinical_study": {
        "@rank": "136123", 
        "arm_group": [
            {
                "arm_group_label": "MTZ 2 g and PDPT", 
                "arm_group_type": "Experimental", 
                "description": "Single dose MTZ and Patient delivered partner treatment"
            }, 
            {
                "arm_group_label": "MTZ 2 g and Partner referral", 
                "arm_group_type": "Active Comparator", 
                "description": "Single dose MTZ and Partner referral"
            }, 
            {
                "arm_group_label": "Metronidazole 250 mg BID and PDPT", 
                "arm_group_type": "Experimental", 
                "description": "Multi dose MTZ and patient delivered partner treatment"
            }, 
            {
                "arm_group_label": "MTZ 250 mg BID and Partner referral", 
                "arm_group_type": "Experimental", 
                "description": "Multi dose MTZ and partner referral"
            }
        ], 
        "brief_summary": {
            "textblock": "The overall goal of this project is to determine the influence of patient treatment, host\n      factors and partner treatment on repeat Trichomonas vaginalis (TV) infections among\n      HIV-negative women"
        }, 
        "brief_title": "Trichomonas Vaginalis Repeat Infections Among HIV Negative Women", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Vaginitis Trichomonal or Due to Trichomonas", 
            "Partner Communication"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Trichomonas Infections", 
                "Trichomonas Vaginitis", 
                "Vaginitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study is a phase IV two-factorial (dosing and partner treatment) randomized clinical\n      trial. HIV-negative women who test positive for TV at their routine gynecological exam at\n      participating clinics will be referred to the nurse/study coordinator to screen for\n      eligibility, provide a description of the study, and obtain written, informed consent\n      (N=2883). Subjects will undergo an audio computer assisted self- interview (ACASI), and will\n      self-collect a vaginal swab for Gram stain testing and be randomized into one of four arms\n      based on 2 factors; dosing -- metronidazole (MTZ) 2 g single dose (CDC recommended treatment\n      regimen) or MTZ 500 mg BID 7-day dose (CDC alternative treatment regimen); and partner\n      treatment -- patient-delivered partner treatment (PDPT) or partner referral (PR). The four\n      arms are MTZ single dose/PDPT, MTZ single dose/PR, MTZ 7d dose/PDPT, and MTZ 7d dose/PR. All\n      enrolled women will be asked to return for a follow-up visit at one month after baseline\n      (window 4-6 weeks)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  female\n\n          -  English speaking\n\n          -  >= 18 years old (Crossroads and Delgado); >=19 years old (JCDH)\n\n        Exclusion Criteria:\n\n          -  HIV-infected\n\n          -  unable to provide informed consent"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "2883", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01832480", 
            "org_study_id": "4042013"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Metronidazole 250 mg BID and PDPT", 
                    "MTZ 250 mg BID and Partner referral"
                ], 
                "description": "MTZ 250 mg BID", 
                "intervention_name": "MTZ 250 mg BID", 
                "intervention_type": "Drug", 
                "other_name": "Multi-dose"
            }, 
            {
                "arm_group_label": [
                    "MTZ 2 g and PDPT", 
                    "Metronidazole 250 mg BID and PDPT"
                ], 
                "description": "patient delivered partner treatment of MTZ", 
                "intervention_name": "PDPT", 
                "intervention_type": "Drug", 
                "other_name": "Patient delivered partner treatment"
            }, 
            {
                "arm_group_label": [
                    "MTZ 2 g and PDPT", 
                    "MTZ 2 g and Partner referral"
                ], 
                "description": "MTZ 2 g", 
                "intervention_name": "MTZ 2 g", 
                "intervention_type": "Drug", 
                "other_name": "Single dose MTZ"
            }, 
            {
                "arm_group_label": [
                    "MTZ 2 g and Partner referral", 
                    "MTZ 250 mg BID and Partner referral"
                ], 
                "description": "Partner Referral to seek treatment", 
                "intervention_name": "Partner referral", 
                "intervention_type": "Other", 
                "other_name": "Partner Referral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Metronidazole"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Trichomonas vaginalis", 
            "metronidazole", 
            "Patient-delivered partner treatment"
        ], 
        "lastchanged_date": "March 1, 2014", 
        "location": [
            {
                "contact": {
                    "email": "cmuzny@uab.edu", 
                    "last_name": "Christina Muzny, MD", 
                    "phone": "205-975-3298"
                }, 
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35233"
                    }, 
                    "name": "Jefferson County Dept of Health/STD Specialty Clinic"
                }, 
                "investigator": {
                    "last_name": "Christins Muzny, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "STaylo2@lsuhsc.edu", 
                    "last_name": "Stephanie Taylor, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "Delgado Personal Health Center"
                }, 
                "investigator": {
                    "last_name": "Stephanie Taylor, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lmena@umc.edu", 
                    "last_name": "Leandro Mena, MD", 
                    "phone": "601-937-2387"
                }, 
                "facility": {
                    "address": {
                        "city": "Jackson", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "39213"
                    }, 
                    "name": "Crossroads Clinic"
                }, 
                "investigator": {
                    "last_name": "Harold Henderson, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Trichomonas Vaginalis Repeat Infections Among HIV Negative Women", 
        "overall_contact": {
            "email": "kissing@tulane.edu", 
            "last_name": "Patricia Kissinger, PhD"
        }, 
        "overall_official": {
            "affiliation": "Tulane Univeristy", 
            "last_name": "Patricia Kissinger, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "TV negative after treatment with either multi or single dose MTZ", 
            "safety_issue": "No", 
            "time_frame": "1 month post treatment completion"
        }, 
        "reference": [
            {
                "PMID": "19008776", 
                "citation": "Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009 Jan;36(1):11-6."
            }, 
            {
                "PMID": "18444815", 
                "citation": "Kissinger P, Secor WE, Leichliter JS, Clark RA, Schmidt N, Curtin E, Martin DH. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis. 2008 Apr 1;46(7):994-9."
            }, 
            {
                "PMID": "16531939", 
                "citation": "Kissinger P, Schmidt N, Mohammed H, Leichliter JS, Gift TL, Meadors B, Sanders C, Farley TA. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis. 2006 Jul;33(7):445-50."
            }, 
            {
                "PMID": "21423852", 
                "citation": "Kissinger P, Mena L, Levison J, Clark RA, Gatski M, Henderson H, Schmidt N, Rosenthal SL, Myers L, Martin DH. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):565-71. doi: 10.1097/QAI.0b013e3181eda955."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01832480"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tulane University Health Sciences Center", 
            "investigator_full_name": "Patricia Kissinger", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Tulane University Health Sciences Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tulane University Health Sciences Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}